XOR-IDH3α轴调控肝细胞癌中巨噬细胞极化
该研究检测肝细胞癌(HCC)组织及癌旁组织中巨噬细胞的XOR水平,并用髓系或Kupffer细胞Xdh特异性敲除小鼠建立HCC模型。发现HCC肿瘤相关巨噬细胞(TAM)中XOR表达下调且与患者生存正相关,单核细胞来源TAM中XOR缺失促进M2极化和CD8+ T细胞耗竭,XOR通过结合IDH3α催化位点抑制α-酮戊二酸生成。
要点
- HCC的TAM中XOR表达下调,且与患者生存正相关。
- 单核细胞来源TAM中XOR缺失促进M2极化和CD8+ T细胞耗竭,加剧HCC进展。
- XOR-IDH3α轴介导TAM极化,可能成为HCC小分子或免疫治疗靶点。
核心结论
- XOR-IDH3α轴介导TAM极化和HCC进展,可能成为针对免疫抑制性HCC TAM的小分子治疗或免疫治疗靶点。
研究设计与样本
- 评估HCC组织及配对癌旁组织中巨噬细胞的XOR水平。
- 用髓系细胞谱系(Xdhf/fLyz2cre)或Kupffer细胞(Xdhf/fClec4fcre)Xdh特异性敲除小鼠建立二乙基亚硝胺/四氯化碳(CCl4)诱导及原位植入HCC小鼠模型。
- 采用代谢组学和代谢流等特定方法确定代谢差异。
主要发现
- HCC TAM中XOR表达下调,且与患者生存正相关,与肿瘤微环境特征特别是缺氧密切相关。
- 单核细胞来源TAM而非Kupffer细胞中XOR缺失促进其M2极化和CD8+ T细胞耗竭,加剧HCC进展。
- XOR缺失巨噬细胞内三羧酸循环紊乱,α-酮戊二酸生成增强。
- XOR通过结合IDH3α催化位点(K142和Q139)抑制α-酮戊二酸生成。
- IDH3α活性增加导致TAM中腺苷和犬尿喹啉酸生成增加,增强TAM和CD8+ T细胞的免疫抑制效应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Tumor-associated macrophages (TAMs) are indispensable in the hepatocellular carcinoma (HCC) tumor microenvironment. Xanthine oxidoreductase (XOR), also known as xanthine dehydrogenase (XDH), participates in purine metabolism, uric acid production, and macrophage polarization to a pro-inflammatory phenotype. However, the role of XOR in HCC-associated TAMs is unclear. METHODS: We evaluated the XOR level in macrophages isolated from HCC tissues and paired adjacent tissues. We established diethylnitrosamine/carbon tetrachloride (CCl4)-induced and orthotopically implanted HCC mouse models using mice with Xdh-specific depletion in the myeloid cell lineage (Xdhf/fLyz2cre) or Kupffer cells (Xdhf/fClec4fcre). We determined metabolic differences using specific methodologies, including metabolomics and metabolic flux. RESULTS: We found that XOR expression was downregulated in HCC TAMs and positively correlated with patient survival, which was strongly related to the characteristics of the tumor microenvironment, especially hypoxia. Using HCC-inflicted mice (Xdhf/fLyz2cre and Xdhf/fClec4fcre), we revealed that XOR loss in monocyte-derived TAMs rather than Kupffer cells promoted their M2 polarization and CD8+ T-cell exhaustion, which exacerbated HCC progression. In addition, the tricarboxylic acid cycle was disturbed, and the generation of α-ketoglutarate was enhanced within XOR-depleted macrophages. XOR inhibited α-ketoglutarate production by interacting with IDH3α catalytic sites (K142 and Q139). The increased IDH3α activity caused increased adenosine and kynurenic acid production in TAMs, which enhanced the immunosuppressive effects of TAMs and CD8+ T cells. CONCLUSIONS: The XOR-IDH3α axis mediates TAM polarization and HCC progression and may be a small-molecule therapeutic or immunotherapeutic target against suppressive HCC TAMs. IMPACT AND IMPLICATIONS: Immunotherapies have been widely applied to the treatment of hepatocellular carcinoma (HCC), but to date they have been associated with unsatisfactory efficacy. The tumor microenvironment of HCC is full of different infiltrating immune cells. Tumor-associated macrophages (TAMs) are vital components in the tumor microenvironment and are involved in HCC progression. Herein, we confirm the downregulation of XOR expression in TAMs isolated from human HCC. The loss of XOR in monocyte-derived macrophages increases IDH3 activity and results in an increase in α-ketoglutarate production, which can promote M2-like polarization. Additionally, XOR-null TAMs derived from monocytes promote CD8+ T-cell exhaustion via the upregulation of immunosuppressive metabolites, including adenosine and kynurenic acid. Given the prevalence and high rate of incidence of HCC and the need for improved therapeutic options for patients, our findings identify potential therapeutic targets that may be further studied to develop improved therapies.
引用
- Lu Y, Sun Q, Guan Q, et al. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma. J Hepatol. 2023. PMID: 37473847. doi:10.1016/j.jhep.2023.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。